Exploration of cornea permeable calpain inhibitors as anticataract agents

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 7, 2003, Pages 1371-1379

  Nakamura, Masayuki ^a   Yamaguchi, Masazumi ^a   Sakai, Osamu ^a   Inoue, Jun ^a  

^a SENJU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [(4 FLUOROPHENYL)SULFONYLAMINO] 3 METHYL N (TETRAHYDRO 2 HYDROXY 3 FURANYL)BUTANAMIDE; 4 METHYL 2 (3 PHENYLTHIOUREIDO) N (TETRAHYDRO 2 HYDROXY 3 FURANYL)PENTANAMIDE; CALPAIN; N (1 FORMYL 3 METHYLBUTYL) 3 METHYL 2 [(3 PYRIDYLMETHYL)CARBONYLAMINO]BUTANAMIDE; N BUTYL 3 [2 [(4 FLUOROPHENYL)SULFONYLAMINO] 3 METHYLBUTANOYLAMINO] 5 METHYL 2 OXOHEXANAMIDE; PROTEINASE INHIBITOR; SJA 6017; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CHEMICAL MODIFICATION; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG SOLUBILITY; DRUG SYNTHESIS; LENS; NONHUMAN; PROTEINASE INHIBITION; RAT; TISSUE CULTURE;

EID: 0037375654     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00612-0     Document Type: Article

References (14)

1. (a) Ono, Y.; Sorimachi, H.; Suzuki, K. In Calpain: Pharmacology and Toxicology of Calcium-Dependent Protease; Wang, K. K. W.; Yuen, P.-W., Eds.; Taylor & Francis; Philadelphia, 1999; pp 1-23.
2. (b) Huang Y., Wang K.K.W. Trends Mol. Med. 7:2001;355.
3. (a) Wang K.K.W., Yuen P.-W. Trends Pharmacol. Sci. 15:1994;412
4. (b) Stracher A. Ann. N. Y. Acad. Sci. 884:1999;52.
5. (a) Shih M., David L.L., Lampi K.J., Ma H., Fukiage C., Azuma M., Shearer T.R. Curr. Eye. Res. 22:2001;458
6. (b) Shearer T.R., David L.L., Anderson R.S. Curr. Eye. Res. 6:1987;289.
7. (a) Fukiage C., Azuma M., Nakamura Y., Tamada Y., Nakamura M., Shearer T.R. Biochim. Biophys. Acta. 1361:1997;304
8. (b) Azuma M., David L.L., Shearer T.R. Biochim. Biophys. Acta. 1180:1992;215.
9. van De Waterbeemd H., Smith D.A., Beaumont K., Walker D.K. J. Med. Chem. 26:2001;1313.
10. Bartus R.T., Baker K.L., Heiser A.D., Sawyer S.D., Dean R.L., Elliott P.J., Straub J.A. J. Cereb. Blood Flow Metab. 14:1994;537.
11. Ando, R.; Sakaki, T.; Masuda, H.; Inakoshi, N.; Jikihara, T.; Fujimura, Y.; Niwa, T.; Yoshii, N.; Tabata, R. Patent WO9625408, 1996, Chem. Abstr. 1996, 125, 300810.
12. Semple J.E., Owens T.D., Nguyen K., Levy O.E. Org. Lett. 2:2000;2769.
13. Calpena A.C., Blanes C., Moreno J., Obach R., Domenech J. J. Pharm. Sci. 83:1994;29.
14. Buroker-Kilgore M., Wang K.K.W. Anal. Biochem. 208:1993;387.